More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a new study says. In 2024, GlaxoSmithKline withdrew Flovent from the market.

More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a new study says. In 2024, GlaxoSmithKline withdrew Flovent from the market.

A Medicaid policy change left fewer kids with access to an asthma inhaler Children were more likely to have no asthma inhaler after GlaxoSmithKline withdrew Flovent from the market GSK withdrew ...

In 2024, GlaxoSmithKline withdrew Flovent from the market. The inhaler was commonly prescribed to prevent asthma attacks in children. The pharma company continued to sell a chemically identical ...

Asthma inhaler access dropped from nearly 41% to nearly 35% between 2021 and 2023 among patients 18 and younger prescribed Flovent (fluticasone), researchers found. By comparison, young asthma ...

Young man using medicine dry powder inhaler for treatment asthma or COPD diseases. Pharmaceutical product is used to treat lung inflammation and prevent asthma attack. Close up. A Medicaid policy ...

The market withdrawal of the brand-name asthma drug fluticasone propionate (Flovent) was linked to increased discontinuation of inhaled steroid therapy among children who had used the drug ...

Arizona sued drug manufacturer GlaxoSmithKline over what it calls deceptive practices involving the inhaled corticosteroid Flovent that endangered asthma patients. The lawsuit filed Thursday in ...

GSK halted manufacturing its Flovent HFA and Flovent Diskus fluticasone propionate inhalers in January. As a result of this, three types of asthma encounter rates went up. Following the ...